ORTHO TRI-CYCLEN TABLETS (norgestimate/ethinyl estradiol)
Answer Center
Birth Control
ORTHO TRI-CYCLEN
Women's Health

Learn about our latest birth control pill

Which Birth Control method is right for you? Find out now.

 
 
About ORTHO TRI-CYCLEN Answer Center Acne
 
Home Site Guide Contact Us Privacy Policy Full US Prescribing Information
Clinically proven to help your skin look better.
 
Birth Control
Quick Facts
The Pill was first introduced in the United States in 1960.
 
The Pill has been the subject of more than 73,000 publications and scientific reviews during its 40-year history.
 
The Pill is the most popular method of reversible birth control in the US, with approximately 12 million women currently using it.
 
Eight of 10 women in the United States have used the birth control pill at some point in their lives.
 
Four of 10 American women between the ages of 18 to 24 currently take the Pill.
 
Nearly half of women choosing a birth control method for the first time, opt for the Pill.
 
Ninety-five percent of Pill users say they are satisfied with it; nearly
80 percent of all American women say they have a positive opinion of the Pill.

 

 

 
 

Important Safety Information
Serious as well as minor side effects have been reported with the use of oral contraceptives. Serious risks, which can be life threatening, include blood clots, stroke and heart attacks, and are increased if you smoke cigarettes. Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you are over 35. Women who use oral contraceptives are strongly advised not to smoke. Some women should not use the Pill, including women who have blood clots, certain cancers, a history of heart attack or stroke, as well as those who are or may be pregnant. The Pill does not protect against HIV or sexually transmitted diseases.

Please click here for full Prescribing Information.


Ortho Women's Health & Urology   All contents Copyright Ortho-McNeil Pharmaceutical, Inc. 2002-2007. All rights reserved.
Your use of the information on this site is subject to the terms of our Legal Notice.
Please see our Privacy Policy.